Moneycontrol PRO
Loans
Loans
HomeNewsTrendsEntertainmentOnly 12 of 332 COVID-19 claims in ads in FY21 were true, says ad regulator ASCI

Only 12 of 332 COVID-19 claims in ads in FY21 were true, says ad regulator ASCI

'Brands that offer proven benefits to consumers have a genuine role in the pandemic, but unfortunately most of the COVID-19 related advertising fell woefully short. Most advertisers were unable to prove that the products actually worked to help consumers in a real way as claimed in the ads,' according to ASCI Secretary General Manisha Kapoor

July 26, 2021 / 13:34 IST
Representative image

Barely 12 of the 332 advertisements for a range of products claiming to provide benefits related to COVID-19 made valid claims, as brands exploited consumer vulnerabilities to peddle their goods during the pandemic, the Advertising Standards Council of India (ASCI) said.

The self-regulatory, voluntary organization of the advertising industry in India assessed advertisements of paints, apparel, detergents, skin care, ACs, fans, water purifiers, plywood and laminates, supplements and food- all promising COVID-19-related benefits.

It picked 332 COVID-19 related ads through consumer complaints as well as its own monitoring and found that brands were taking .

ASCI’s expert panel that comprises microbiologists examined COVID-19 related evidence provided by advertisers.

Given the rampant exploitation of vulnerable consumers in the pandemic situation, ASCI issued a COVID-19 advisory in October 2020, giving advertisers a clear directive to fully substantiate their COVID-19 related claims through recognized testing facilities.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

“In a period where consumer vulnerabilities were at an all-time high, many brands took unfair advantage of this, and tried to peddle their wares without establishing any robust evidence of their actual utility against the SARS Cov-2 virus. Brands that offer proven benefits to consumers have a genuine role in the pandemic, but unfortunately most of the COVID-19 related advertising fell woefully short. Most advertisers were unable to prove that the products actually worked to help consumers in a real way as claimed in the ads,” said Manisha Kapoor, Secretary General, ASCI.

Besides COVID-19 complaints, the ASCI Consumer Complaints Council (CCC) also processed 1,406 complaints in the education sector, 285 complaints against food and beverage advertisements and 147 complaints related to personal care.

In addition, 364 advertisements were found to be, prima facie, in violation of The Drugs and Magic Remedies Act.

Overall, ASCI last year processed over 6,149 complaints and saw compliance at 97 percent.

Also, in the first quarter last year, following a directive from the Ministry of AYUSH asking for ASCI to identify advertisements that violated its advisory dated April 1, 2020, ASCI escalated 237 objectionable ads to the government.

While 164 ads complied and modified the untrue claims, 73 COVID-19 related ads needed further investigation and action by the Ministry due to non-compliance.

Last year, the ad regulator had tied up with TAM to monitor 3,000 digital platforms.

Since then, it has observed a rise in complaints related to online ads, both received from end consumers, as well as taken up suo motu.

Also, out of the 6,149 complaints, 35 percent were from digital.

The pandemic year also saw a massive jump in online gaming activities and concerned with the unabated rise of online real money gaming advertisements which did not explain risks to consumers in a transparent way.

For this, ASCI developed guidelines for the sector. ASCI processed 67 complaints related to online real money gaming from January-March 2021.

Follow Moneycontrol’s full coverage of the coronavirus pandemic here
Maryam Farooqui
first published: Jul 26, 2021 01:34 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347